Emergency Management of Hyperkalemia in Children
In acute pediatric hyperkalemia, immediately administer IV calcium gluconate (or calcium chloride) for cardiac membrane stabilization if ECG changes are present or potassium ≥6.5 mEq/L, followed by combination therapy with IV insulin-dextrose and nebulized salbutamol to shift potassium intracellularly 1, 2, 3.
Immediate Assessment and Cardiac Protection
First, obtain an ECG immediately to assess for life-threatening cardiac manifestations. Look specifically for:
- Tall, peaked T waves (earliest sign)
- Widened QRS complex
- Prolonged PR interval
- Loss of P waves
- Sine wave pattern (pre-arrest rhythm)
2 demonstrates the classic progression of ECG changes with increasing potassium levels in a pediatric case with potassium of 10.7 mEq/L, where calcium gluconate produced immediate resolution of ECG abnormalities.
Administer IV calcium immediately if any ECG changes are present or if serum potassium ≥6.5 mEq/L 3. Use:
- Calcium gluconate 10%: 0.5-1 mL/kg (maximum 10 mL) IV over 2-5 minutes with continuous cardiac monitoring
- Effect occurs within 1-3 minutes but does NOT lower potassium—it only stabilizes cardiac membranes 4, 2
- Duration of effect is 30-60 minutes; may need to repeat
Intracellular Potassium Shift (Primary Treatment)
After cardiac stabilization, immediately initiate combination therapy to shift potassium intracellularly:
Insulin-Dextrose Therapy
- Regular insulin 0.1 units/kg (adult dose: 10 units) with dextrose 0.5-1 g/kg (adult: 50 mL of D50W) IV 4, 1
- Onset: 30-60 minutes
- Duration: 4-6 hours
- Critical pitfall: Monitor glucose closely for 4-6 hours post-treatment as hypoglycemia is common, particularly in non-diabetic children with lower baseline glucose 3
Beta-2 Agonist Therapy
Nebulized salbutamol is highly effective in children and should be used in combination with insulin 5, 3. A pediatric study of 15 children demonstrated:
- Dose: 5 mcg/kg (adult: 10-20 mg in 4 mL) nebulized over 15 minutes 5
- Potassium decreased from mean 6.6 to 5.74 mEq/L at 30 minutes, continuing to 4.92 mEq/L at 120 minutes
- Well-tolerated with only mild tachycardia in 3 patients
- Provides synergistic effect with insulin 3
- Duration: 2-4 hours (shorter than insulin) 4
The combination of insulin-dextrose plus salbutamol is more effective than either agent alone 3.
Potassium Elimination
After stabilization and intracellular shift, focus on removing potassium from the body:
Loop Diuretics
- Furosemide 1 mg/kg IV in patients with adequate urine output and volume overload 4, 1
- Only effective if kidney function is preserved (non-oliguric)
- Monitor for hypovolemia
Sodium Bicarbonate
- Reserved ONLY for patients with concurrent metabolic acidosis 4, 3
- Dose: 1-2 mEq/kg IV over 5-10 minutes
- Evidence for efficacy is limited in absence of acidosis 3
Hemodialysis
- Definitive treatment for severe, refractory hyperkalemia or oliguric/anuric renal failure 4, 1
- Consider early in patients with:
- End-stage renal disease
- Oliguria/anuria
- Potassium >8 mEq/L unresponsive to medical therapy
- Ongoing tissue breakdown (rhabdomyolysis, tumor lysis)
What NOT to Use
Avoid sodium polystyrene sulfonate (Kayexalate) in acute pediatric emergencies 3. This agent:
- Has questionable efficacy in acute settings
- Carries risk of gastrointestinal adverse events including intestinal necrosis
- Takes hours to work, making it inappropriate for emergency management
Monitoring Strategy
- Continuous cardiac monitoring during acute treatment
- Recheck potassium at 1-2 hours, then every 2-4 hours until stable
- Monitor glucose every 1-2 hours for 6 hours after insulin administration 3
- Reassess ECG after each intervention
Common Pitfalls to Avoid
- Pseudohyperkalemia: Confirm with repeat sample if clinically inconsistent—hemolysis, prolonged tourniquet time, and fist clenching falsely elevate results 4, 1
- Delaying calcium: Do not wait for laboratory confirmation if ECG shows hyperkalemic changes—treat immediately 2
- Insulin without glucose monitoring: Hypoglycemia can be as dangerous as hyperkalemia 3
- Using only one shifting agent: Combination therapy (insulin + salbutamol) is more effective 3
- Forgetting to address the underlying cause: Identify triggers (medications, renal failure, adrenal insufficiency, tissue breakdown) 6, 2
Special Pediatric Considerations
In neonates and infants, consider:
- Congenital adrenal insufficiency (as demonstrated in 2)
- Adjust medication doses by weight
- Smaller blood volumes require careful fluid management
- Lower threshold for nephrology consultation
The algorithmic approach is: (1) ECG → (2) IV calcium if indicated → (3) Insulin-dextrose + nebulized salbutamol simultaneously → (4) Eliminate potassium via diuretics or dialysis → (5) Identify and treat underlying cause 1, 6.